351 related articles for article (PubMed ID: 26545932)
1. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.
Lai Y; Dong C
Int Immunol; 2016 Apr; 28(4):181-8. PubMed ID: 26545932
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Targeting by miRNAs in Autoimmune Diseases.
Salvi V; Gianello V; Tiberio L; Sozzani S; Bosisio D
Front Immunol; 2019; 10():15. PubMed ID: 30761124
[TBL] [Abstract][Full Text] [Related]
3. Pro- and anti-inflammatory cytokines in rheumatoid arthritis.
Isomäki P; Punnonen J
Ann Med; 1997 Dec; 29(6):499-507. PubMed ID: 9562516
[TBL] [Abstract][Full Text] [Related]
4. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Maddur MS; Miossec P; Kaveri SV; Bayry J
Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
[TBL] [Abstract][Full Text] [Related]
5. Cytokine inhibitors in autoimmune disease.
Weckmann AL; Alcocer-Varela J
Semin Arthritis Rheum; 1996 Oct; 26(2):539-57. PubMed ID: 8916298
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
Prud'homme GJ
J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
[TBL] [Abstract][Full Text] [Related]
7. Cytokine inhibition in the treatment of COPD.
Caramori G; Adcock IM; Di Stefano A; Chung KF
Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
[TBL] [Abstract][Full Text] [Related]
8. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases.
Kuwabara T; Ishikawa F; Kondo M; Kakiuchi T
Mediators Inflamm; 2017; 2017():3908061. PubMed ID: 28316374
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic benefits of regulating inflammation in autoimmunity.
Nikoopour E; Schwartz JA; Singh B
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
[TBL] [Abstract][Full Text] [Related]
10. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
Yamagata T; Skepner J; Yang J
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
[TBL] [Abstract][Full Text] [Related]
11. Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases.
Wu X; Tian J; Wang S
Front Immunol; 2018; 9():1112. PubMed ID: 29892286
[TBL] [Abstract][Full Text] [Related]
12. The pathogenicity of Th17 cells in autoimmune diseases.
Yasuda K; Takeuchi Y; Hirota K
Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
[TBL] [Abstract][Full Text] [Related]
13. Anti-cytokine antibodies for rheumatic diseases.
Atzeni F; Sarzi-Puttini P
Curr Opin Investig Drugs; 2009 Nov; 10(11):1204-11. PubMed ID: 19876788
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in uveitis.
Weinstein JE; Pepple KL
Curr Opin Ophthalmol; 2018 May; 29(3):267-274. PubMed ID: 29521875
[TBL] [Abstract][Full Text] [Related]
15. Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis.
Guo K; Zhang X
J Immunol Res; 2021; 2021():6693542. PubMed ID: 33816637
[TBL] [Abstract][Full Text] [Related]
16. IL-17 Signaling: The Yin and the Yang.
Amatya N; Garg AV; Gaffen SL
Trends Immunol; 2017 May; 38(5):310-322. PubMed ID: 28254169
[TBL] [Abstract][Full Text] [Related]
17. Current Understanding of IL-37 in Human Health and Disease.
Su Z; Tao X
Front Immunol; 2021; 12():696605. PubMed ID: 34248996
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications.
Arranz L; Arriero MDM; Villatoro A
Blood Rev; 2017 Sep; 31(5):306-317. PubMed ID: 28495184
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18: a regulator of cancer and autoimmune diseases.
Esmailbeig M; Ghaderi A
Eur Cytokine Netw; 2017 Nov; 28(4):127-140. PubMed ID: 29478963
[TBL] [Abstract][Full Text] [Related]
20. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
